Reducing Skin Cancer Risk in Childhood Cancer Survivors
Completed · Not applicable
Conditions studied: Skin Neoplasms
In brief
The objective of this study is to determine the impact of a 12-month patient activation and education intervention on skin cancer early detection practices among childhood cancer survivors treated with radiation. This randomized controlled trial uses a three-group design. Our specific aims are to: (1) Determine the impact of a Patient Activation and Education intervention with and without physician activation and teledermatology on skin cancer early detection practices, (2) Determine the impact of the intervention on time to diagnosis, and (3) Estimate the cost and cost-effectiveness of the intervention as a secondary outcome.
Key facts
- Study ID
- NCT02046811
- Run by
- Harvard School of Public Health (HSPH)
- People needed
- 726
- Starts
- 2015-03-01
- Expected to finish
- 2018-01-01
- Last updated by the study team
- 2018-06-20
Who can join
Age: 30 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- treated with radiation for a childhood cancer
- have a regular healthcare provider whom he/she has seen in the previous 2 years, or plans to see in the next year
- have a phone that can receive text messages
- have access to a dermlite compatible smartphone or tablet
You may not qualify if…
- personal history of a skin cancer diagnosis
Where it is running
- St. Jude Children's Research Hospital — Memphis, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.